Dr. Jennifer Walden’s Contribution to the Cosmetic Surgery Practice

Jennifer Walden is a fellowship-trained, Board-certified Texas-based plastic surgeon who specializes in Cosmetic surgeries. She is also a prolific media commentator, and the sole founder of the Jennifer L. Walden, M.D., PLLC and the Walden Cosmetic Surgery Center. The center is privately owned, and among its service catalog are ambulatory surgical services. With its subsidiary facility in Marble Falls, TX, the brand offers individuals aesthetic cosmetic health services that ultimately change their entire outlook on life.

Dr. Walden partakes actively as a board member of the highly acclaimed American Society for Aesthetic Plastic Surgery. She also acts in full capacity as a member of the American Society of Plastic Surgeons, together with a fellowship link to the American College of Surgeons. Her media commentary skills cannot go unspoken, for she is the spokesperson of the ASAPS and the ASPS and learn more about Dr. Walden Reviews.

For the eight years she has been in practice, Dr. Jennifer Walden Reviews has exclusively specialized in cosmetic surgical procedures, including breast augmentation, facelifts and eyelid lifts, and nose jobs. She charges her clients depending on the sort of operation. That said; clients in need of a breast augmentation pay about $ 7000, while facelifts and nose jobs cost about $ 10, 000 and $ 9000. Her professional skills have also rendered her a competent surgeon in liposuction and simple surgeries like soft-tissue fillers.

She acquired her fellowship halo in aesthetic surgery in 2004. Back then she was under Dr. Sherrell Aston, the department’s chair at the Manhattan ENT health center, from where she acquired her fellowship with the aesthetic surgery society.

Following the end of her residence in the Manhattan ENT Hospital, she, later on, moved to Upper East Side New York, where she worked for seven years, six months. While operating in New York, she actively partook in the clinical research that eventually hatched the launch of silicone breast implants and more information click here.

Dr. Walden moved back to her native homeland, Austin, Texas in 2011 shortly before she gave birth to her twin sons. Her return to Texas allowed her to start up a cosmetic surgery center in Westlake Hills and the Marble Falls satellite quarters and Dr. Walden’s lacrosse camp.

Mikhail Blagosklonny Breaking New Ground in Cancer Research And The Race For Longevity

Mikhail Blagosklonny, a renowned doctor, scientist, and biologist specializing in oncology and the field of anti-aging research and medicine. He earned his Ph.D. in Experimental Medicine and Cardiology from St. Petersburg’s First Pavlov State Medical University. He also previously received his master’s degree in Internal Medicine from the same institution.

Over the years, Mikhail has enjoyed a long and prolific career in cancer and anti-aging research. He began his work at the NY Medical College as an Associate Professor of Medicine in 2002.After this, Blagosklonny was appointed lead Scientist at New York’s Ordway Research Institute. View Mikhail’s profile in LinkedIn

After he left the institution, he was tapped to be the Oncology professor at the Roswell Park Cancer Institute in 2009, a position he still holds today.

Blagosklonny’s work is focused on cancer, mainly researching guided therapy techniques that prevent damage to healthy cells. He is also well-known for his research into the fundamental processes of aging, as well as anti-aging drug therapies.

He is particularly known for his hypothesis regarding the role of Target Of Rapamycin signaling in cancer and aging. Blagosklonny’s work in this theory has received wide acclaim, mainly because it suggests headway in discovering a cure for cancer and ensuring longevity in humans. His hypothesis widely suggests the use of popular anti-aging and cancer drug Rapamycin.

Apart from his teaching and research work at Roswell Park, Blagosklonny spends most of his time these days writing and editing peer review journals, especially for cancer and longevity-related tomes. He currently serves as chief editor at the publications Oncotarget, Aging – which deals with research into aging, senescence, gerontology, and molecular mechanics -and Cell Cycle. He is also the Associate Editor at Cancer Biology and Therapy, as well as serving on the panel of the Cell Death &Differentiation publication’s editorial board.

Mikhail Blagosklonny is a published author, with more than 200 papers published in peer-reviewed journals, with over 20,000 citations to his name. Many of his papers detail research into the subjects of cancer cell cycles, tumor suppression, signal transduction, and aging and longevity.

He also enjoys a successful speaking career that gives him the opportunity to lecture in a number of prestigious schools and universities, as well as health-related institutions. Check Mikhail’s profile on Loop